- Home
- PACB vs BNTC Comparison
PACB vs BNTC Comparison
Compare PACB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- BNTC
- Stock Information
- Founded
- PACB 2000
- BNTC 1995
- Country
- PACB United States
- BNTC United States
- Employees
- PACB N/A
- BNTC N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- PACB Industrials
- BNTC Health Care
- Exchange
- PACB Nasdaq
- BNTC Nasdaq
- Market Cap
- PACB 364.2M
- BNTC 352.5M
- IPO Year
- PACB 2010
- BNTC N/A
- Fundamental
- Price
- PACB $1.20
- BNTC $13.74
- Analyst Decision
- PACB Buy
- BNTC Strong Buy
- Analyst Count
- PACB 10
- BNTC 7
- Target Price
- PACB $2.45
- BNTC $24.71
- AVG Volume (30 Days)
- PACB 6.5M
- BNTC 37.1K
- Earning Date
- PACB 05-08-2025
- BNTC 05-16-2025
- Dividend Yield
- PACB N/A
- BNTC N/A
- EPS Growth
- PACB N/A
- BNTC N/A
- EPS
- PACB N/A
- BNTC N/A
- Revenue
- PACB $154,014,000.00
- BNTC N/A
- Revenue This Year
- PACB $6.13
- BNTC N/A
- Revenue Next Year
- PACB $21.55
- BNTC N/A
- P/E Ratio
- PACB N/A
- BNTC N/A
- Revenue Growth
- PACB N/A
- BNTC N/A
- 52 Week Low
- PACB $1.06
- BNTC $5.74
- 52 Week High
- PACB $2.72
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- PACB 51.01
- BNTC 51.06
- Support Level
- PACB $1.06
- BNTC $13.10
- Resistance Level
- PACB $1.16
- BNTC $15.69
- Average True Range (ATR)
- PACB 0.06
- BNTC 0.73
- MACD
- PACB 0.01
- BNTC -0.01
- Stochastic Oscillator
- PACB 73.68
- BNTC 24.71
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.